TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/20/2025
Back to search
Official data from USPTO
ADARE PHARMA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/25/2025
Trademark type
Combined
Nice classes
40, 42
Filing date
12/07/2020
Registration date
03/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2022
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/02/2020
First use in commerce
10/02/2020
Drawing code
3
Owner type
03
Owner location
Philadelphia, PA
Examiner
BLOHM, LINDA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "ADARE" with the second capital "A" in the word dissected in the middle by a circle located above the bottom half of the "A" and containing the top half of the "A", in triangle form, with the words "PHARMA SOLUTIONS" located directly below the word "ADARE".
Holders and representatives
Holders
Adare Pharmaceuticals, Inc.
Adare Pharmaceuticals, Inc.
Representatives
Shawn Duckworth Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing of pharmaceutical and nutritional and dietary formulationsto the specifications of othersused as facilitating agents for tabletscapsulespowdersinjectablessuspensionsgelsliquids; Manufacturing services for others of drug delivery products for the immediatecontrolledextendeddelayedpulsatile or local release of a therapeuticnutritional or dietary agent; Manufacturing services for others of pharmaceutical and dietary compositions for use in veterinary administration forms such as tabletscapsulessuspensionsliquids; Manufacturing services for others of particles with specific particle dimension and narrow particle size distributions containing active ingredients
Class 42
Design and development of pharmaceuticalnutritional and dietary formulations; Research and development of drug delivery formulation used as facilitating agents for pharmaceutical tabletscapsulespowdersinjectablessuspensionsgelsliquids; Development of pharmaceutical formulations for veterinary applications; Design and development of preparations in liquid form or solid form for the immediatecontrolledextendeddelayedpulsatile or local release of a therapeutic or dietary agent; Development of particles with defined particle size dimensions and particle size distribution containing active ingredients for pharmaceutical purposes; Technology consultation in the field of pharmaceutical development
Publications
History of USPTO decisions and trademark events.
20 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/20/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/20/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/28/2021
PUBO
PUBLISHED FOR OPPOSITION
12/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/26/2021
GNRT
NON-FINAL ACTION E-MAILED
05/26/2021
CNRT
NON-FINAL ACTION WRITTEN
05/26/2021
DOCK
ASSIGNED TO EXAMINER
05/25/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2021
NWAP
NEW APPLICATION ENTERED
12/10/2020
Continuous trademark protection
Get notified about every new filing that threatens ADARE PHARMA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.